Navigation Links
Onconova Therapeutics Announces Presentation of Clinical and,Non-Clinical Results for Its Lead Compound ON 01910.Na at American,Association of Cancer Research Conference in Los Angeles

. Solomon, F. Chan, M. Zhao, S. Cosenza, M. Reddy, M. Rudek, P. Kulecza, E. P. Reddy and M. Hidalgo (abstract 5391).

About Onconova's Product-Pipeline

Onconova is developing several novel product candidates directed at critical kinase targets involved in the regulation of signal transduction, cell-cycle and DNA repair. These candidates are derived from the Company's proprietary library of new chemical entities and non-ATP competitive chemotypes. In addition to ON 01910.Na, Onconova is also developing Ex-RAD(TM), an injectable and oral radioprotectant, and inhibitors of JAK and Bcr-abl pathways.

About Onconova Therapeutics, Inc.

Onconova, based in Lawrenceville, NJ, discovers and develops novel therapeutic agents for cancer, radiation protection and hematological disorders. Currently, the Company is conducting clinical trials at major centers in the USA and abroad. The novel chemical library platform is permitting identification of non-ATP competitive kinase inhibitors directed at validated and novel targets, and a new immunoconjugate technology for arming monoclonal antibodies for cancer therapy. All of the Company's products and technologies are being developed internally.

For further information on Onconova Therapeutics, Inc., please visit http://www.onconova.com.

All trademarks are registered to their respective owners.

Contact

Investors
Onconova Therapeutics, Inc.
Dr. Ramesh Kumar
President and CEO
609-844-7735
or
Media
KMorrisPR
Kathryn Morris
845-635-9828
kathryn@kmorrispr.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care

Post Your Comments:
(Date:11/23/2009)..., ATLANTA,Nov.23/PRNewswire-FirstCall/-- CryoLife,...viceandcardiovasculartissueprocessingcompany,annou...ngPiperJaffray21stAnnualHealthCareConferenceatTheN...nderson,presidentandchiefexecutiveofficerofCryoLif...ifeandrecentdevelopmentsandhostaquestionandanswers...
(Date:11/23/2009)..., NASHVILLE,Tenn.,Nov.23/PRNewswire-FirstCall/-- C...cedpositivenewtop-lineresultsfromastudyevaluatingt...nintreatingfeverinhospitalizedburnpatients. ,, ...pointofreducingfeverinburnpatientsoverthefirst24ho...swithsecondorthirddegreeburnscoveringmorethan10per...
(Date:11/23/2009)..., LINCOLNSHIRE,Ill.,Nov.23/PRNewswire/--Sarnova,In...areproductsintheemergencymedicalservices(EMS)andre...ourexecutivestoitsseniormanagementteam.Thenewexecu...;DonnaHill,executivevicepresidentandgeneralcounsel...regRobitaille,executivevicepresidentofcorporatedev...
Breaking Medicine Technology:CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Sarnova Expands Senior Management Team 2Photos 3A 2010 All New Kia Soul Awarded 2009 Top Safety Pick by Insurance Institute for Highway Safety 54439 1Photos 3A 2010 All New Kia Soul Awarded 2009 Top Safety Pick by Insurance Institute for Highway Safety 54439 2Photos 3A 2010 All New Kia Soul Awarded 2009 Top Safety Pick by Insurance Institute for Highway Safety 54439 3Thomson Reuters Invites You to the First Latin American Forum Covering the Pharmaceutical Industry 54437 1Thomson Reuters Invites You to the First Latin American Forum Covering the Pharmaceutical Industry 54437 2AVMA Unveils Improved Online Press Room to Help Journalists 54435 1AVMA Unveils Improved Online Press Room to Help Journalists 54435 2AVMA Unveils Improved Online Press Room to Help Journalists 54435 3
...ESTER, Minn., June 26 A new implantable,medical d... researchers,shows promise as a reversible and les...ies, according to findings published in the curren...pen label trial involving three medical centers in...ipants who received the,vagal nerve blocking devic...
...NTA, June 26 Alimera Sciences, Inc., a privately,... the research,development and commercialization of...ported the interim month three safety and efficacy... study of Medidur(TM) FA,which Alimera Sciences in... approved by the U.S. Food and Drug Administration...
Other Medicine Technology:Device Blocking Stomach Nerve Signals Shows Promise in Obesity 2Device Blocking Stomach Nerve Signals Shows Promise in Obesity 3Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study 2Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study 3
(Date:11/23/2009)...toTargetIndividualsintheRecommendedPriorityGroups ...e/--TheDepartmentofHealthannouncedtodaytheywillcon...ateHealthCentersinDelaware,Lancaster,andLehighcoun...ccinewillbeadministeredforfreetoindividualsinthere...othevaccine.Thedepartmentasksthatonlyindividualsin...
(Date:11/23/2009)...cer patients and survivors treated with chemothera...ecome chronic conditions, hindering patients, abil...he University of Rochester Medical Center. , A s...d sleep troubles at nearly three times the rate of...alent in younger patients and those with lung and ...
(Date:11/23/2009)...09) -- A first-of-its-kind consensus statement on ... Annals of Surgery . The report illustrates the fi...ence -- Diabetes Surgery Summit (DSS) -- where an ... medical experts agreed on a set of evidence-based...e the use and study of gastrointestinal surgery to...
(Date:11/23/2009)...mber of patients who reined in their hypertension,...thDay News) -- High blood pressure is better contr...and than by doctors and pharmacists working alone,...h pharmacists, medications are intensified, dosage...aid Barry L. Carter, a professor in the University...
(Date:11/23/2009)...thMinorityBanksin Washington D.C. , NewYorkC...edtoSpurEconomicGrowthandRevitalization ,, WAS...thenation,sleadingproviderofdialysisservices,today...mmunityfora$1millioninvestmentinIndustrialBankaspa...ies. ,, DaVita,sinvestmentinWashington,D.C.ispa...
Breaking Medicine News(10 mins):Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4
...d side to the WinRho drug, used for treating bleed...nc. and Cangene Corp, the drug has a tendency to t... The Winrho drug has been in use in the United Sta... platelets, to form clots. Winrho-related complica...
...mical faecal occult blood test (FOBT) is a simpler...orectal cancer, researchers claim in an article pu...nally, guaiac FOBT is used to screen individuals w...cancer." Lead author Dr Callum G Fraser also sa...
...nown for long now that Vitamin D supplementation h...min D supplementation in pregnant// women could le...ures in their children. According to a study ...medical fact that Vitamin D insufficiency is commo...
...ate of Gujarat has registered a fall in the number... 2004 from 4.48% in 2003.// Where the low risk gro... 0.38% in 2003. The 2005 figures are expected to b... in the state, of which 779 are in the city. If th...
...urgical services provided by NHS could suffer a bi...(Surrey and Sussex) failed to improve, warned the ...cial management, in addition to lack of proper res... trusts and hospitals is believed to reach ?75m by...
...rged by the Federal Government to stockpile medici... bird flu pandemic in America.// A pandemic is sai...s gets transmitted from one person to the other, t...robability of a devastating human-human transmissi...
Other Medicine News:Health News:Gujarat Records Fall In AIDS Cases 2Health News:NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey 2Health News:Bird Flu Threat Prompts Stockpiling Of Food And Medicine In America 2
Finnpipette BioControl Single Channel Modules, 40-200ul
...rch pro Electronic Pipette is ideal for all liquid...-to-follow display, ergonomically-placed operating...s pipetting, dispensing, reverse pipetting and dil...dles the simple functions of a manual pipette with...
Research pro
...ncet Device offers the ease and comfort you've com... in clinical trials agreed that the BD Lancet Devi...ngs allow you to choose the best lancet penetratio...ncets, the device also helps eliminate the "vibrat...
Medicine Products: